This study also confirmed for the first time that GPR37 can promote the EMT of NSCLC and GPR37 can activate the PI3K/Akt/mTOR signal transduction pathway to promote NSCLC progression. This evidence concerns the gene MTOR and non-small cell lung carcinoma.